Genetic and epigenetic regulation of SLC6A4 shapes vulnerability to cognitive decline and depressive tendency in later life

Read full text Summarise with VIRAT
Authors: Yutaro Yanagida, Yutaka Nakachi, Naoto Kajitani, Satoshi Kikkawa, Tempei Ikegame, Shinsuke Koike, Norihide Maikusa, Naohiro Okada, Izumi Naka, Jun Ohashi, Hiroko Sugawara, Kazuhiro Yoshiura
+20 more Ayaka Fujii, Emi Kiyota, Risa Watanabe, Y. Murata, Yasuyuki Taki, Yasuko Tatewaki, Benjamin Thyreau, Yuji Takano, Manabu Makinodan, Norio Sakai, Tomohisa Ishikawa, Yosuke Hidaka, Mamoru Hashimoto, Yoshihiko Furuta, Tomoyuki Ohara, Toshiharu Ninomiya, Kiyoto Kasai, Minoru Takebayashi, Miki Bundo, Kazuya Iwamoto
Cited by: 0
References: 78

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Age-related cognitive decline and depressive symptoms are prevalent in later life, yet the genetic determinants of vulnerability remain unclear. Here, we investigated how genetic and epigenetic regulation of the serotonin transporter gene SLC6A4 contributes to susceptibility to these age-related conditions in later life. In community-dwelling older adults in Japan ( N = 1,317), functional stratification of the serotonin transporter-linked polymorphic region (5-HTTLPR) revealed that participants with low-activity genotypes showed a robust co-occurrence of cognitive decline and depressive symptoms, whereas this comorbid pattern was not observed in those with the high-activity genotype. The genotype-dependent co-occurrence was consistently replicated across seven independent population-based cohorts (total N = 7,889). DNA methylation at a functional promoter CpG site increased with age and partially mediated age-related cognitive decline specifically among low-activity genotypes. In contrast, the high-activity genotype was associated with relative resistance to these functional declines, partly mediated by a protective effect on hippocampal volume during aging. Notably, genotype-dependent effects on hippocampal volume were absent in adolescence, indicating that the influence of SLC6A4 emerges in an aging-specific manner. Together, these findings identify SLC6A4 promoter activity as a key genetic factor modulating vulnerability and resilience in later life.

Fields of Study & Subjects

Neurotransmitter Receptor Influence on Behavior Genetic Associations and Epidemiology Dementia and Cognitive Impairment Research

Publication details

Journal / source
medRxiv
Publication date
28 March 2026
Language
EN
Document type
Preprint